Gadobutrol

CAS No. 770691-21-9

Gadobutrol( ZK 135079 )

Catalog No. M21600 CAS No. 770691-21-9

Gadobutrol is a nonionic paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 32 In Stock
10MG 39 In Stock
25MG 50 In Stock
50MG 60 In Stock
100MG 71 In Stock
200MG 87 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Gadobutrol
  • Note
    Research use only, not for human use.
  • Brief Description
    Gadobutrol is a nonionic paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI).
  • Description
    Gadobutrol is a nonionic paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI).(In Vitro):Gadobutrol leads to a gradual decrease in cell density with increasing concentration under neutron irradiation.(In Vivo):Gadobutrol (intravenous injection, 200 mM, once, a week) can significantly enhance intracerebroventricular cell signaling in female C57BL/6 N mice.
  • In Vitro
    Gadobutrol leads to a gradual decrease in cell density with increasing concentration under neutron irradiation. Cell Viability Assay Cell Line:Human melanoma cell line Sk-Mel-28 Concentration:0-30 mM Incubation Time:1 hour Result:Showed a decrease in cell density to 26% at 30 mM while to 80% with no gadobutrol under neutron irradiation.
  • In Vivo
    Gadobutrol (intravenous injection, 200 mM, once, a week) can significantly enhance intracerebroventricular cell signaling in female C57BL/6 N mice. Animal Model:Female C57BL/6 N mice, 11-13 weeks, 21-23 g)Dosage:200 mM Administration:Intravenous injection; once; a week Result:Enhanced cells signal in the habenula, hippocampal formation, and locus coeruleus.
  • Synonyms
    ZK 135079
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Neurological Disease
  • Indication
    Neoplastic CNS Lesions

Chemical Information

  • CAS Number
    770691-21-9
  • Formula Weight
    604.71
  • Molecular Formula
    C18H31GdN4O9
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:20 mg/mL (33.07 mM; Need ultrasonic)
  • SMILES
    OC[C@H](O)[C@@H]1CO[Gd]234567OC(=O)C[N]22CC[N]3(CC[N]14CC[N]5(CC2)CC(=O)O6)CC(=O)O7
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cheng KT. Gadobutrol. Molecular Imaging and Contrast Agent Database (MICAD)
molnova catalog
related products
  • Tyroserleutide hydro...

    Tyroserleutide hydrochloride is a small molecule tripeptide isolated from the degradation product of pig spleen, which can inhibit tumor growth in vivo and in vitro.

  • Laquinimod

    Laquinimod (ABR-215062) is an immunoregulator derived from Linomide, has been shown to completely inhibit the development of murine acute experimental autoimmune encephalomyelitis (EAE).

  • Rhamnazin

    Rhamnazin is an orally active inhibitor of VEGFR2 signaling with an IC50 of 4.68 μM against VEGFR2 kinase. Rhamnazin shows potent antiangiogenic activity and antitumor efficacy. Rhamnazin shows antioxidant and anti-inflammatory properties.